These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18504430)

  • 21. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
    Hirose Y; Berger MS; Pieper RO
    Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of Cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction.
    Vasilevskaya IA; Rakitina TV; O'Dwyer PJ
    Cancer Res; 2003 Jun; 63(12):3241-6. PubMed ID: 12810654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Fujii Y; Kato T; Kubota N; Fujimori A; Niwa O; Okayasu R
    Oncol Rep; 2010 Jan; 23(1):199-203. PubMed ID: 19956882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.
    Bedin M; Gaben AM; Saucier C; Mester J
    Int J Cancer; 2004 May; 109(5):643-52. PubMed ID: 14999769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat shock protein 90 is important for Sp1 stability during mitosis.
    Wang SA; Chuang JY; Yeh SH; Wang YT; Liu YW; Chang WC; Hung JJ
    J Mol Biol; 2009 Apr; 387(5):1106-19. PubMed ID: 19245816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
    Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
    Wang Y; Li J; Booher RN; Kraker A; Lawrence T; Leopold WR; Sun Y
    Cancer Res; 2001 Nov; 61(22):8211-7. PubMed ID: 11719452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
    Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
    Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
    Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
    Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
    DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
    Aneja R; Ghaleb AM; Zhou J; Yang VW; Joshi HC
    Cancer Res; 2007 Apr; 67(8):3862-70. PubMed ID: 17440101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsp90 chaperones wild-type p53 tumor suppressor protein.
    Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
    J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.
    Petersen L; Hasvold G; Lukas J; Bartek J; Syljuåsen RG
    Cell Prolif; 2010 Aug; 43(4):365-71. PubMed ID: 20590661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.
    Wang X; Heuvelman DM; Carroll JA; Dufield DR; Masferrer JL
    Cancer Invest; 2010 Jul; 28(6):635-41. PubMed ID: 20394503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.